- Medicon Valley
- News & Events
- News
- Events
- Medicon Valley Newsletter
- June 2008
- May 2008
- April 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- November 2005
- October 2005
- September 2005
- Business Opportunities
- Science & Research
- Networks
- Services & Support
- Companies & Institutions
- At Your Service
Medicon Valley Biomedical Newsletter
The Medicon Valley Biomedical Newsletter is intended for decision makers in pharmaceutical and biotech companies, investors and other professionals who wish to keep updated on business related activities in the Medicon Valley.
September
Medicon Valley Biomedical Newsletter September edition is brought to you by Region Skåne and Copenhagen Capacity
The Medicon Valley Biomedical Newsletter has changed format this month and reflects some of the changes planned to improve the newsletter. The top story this month is that Lund University has received EUR 10 Million for stroke research. Find more information on this story and other top news from Medicon Valley in the newsletter below.
Other news from the region are continuously updated on our webpage: www.mediconvalley.com/NewsAndEvents/News
-
Lund University Receives EUR 10 Million for Stroke Research
24 Sep 2007
Two researchers at Lund University have received EUR 10 million for development of a new stroke treatment. The treatments existing today prevent tissue damage, but these treatments are not effe...
-
Lundbeck and Takeda Form Alliance
6 Sep 2007
H. Lundbeck A/S and Takeda Pharmaceutical Company Limited have announced a strategic alliance for the exclusive co-development and co-commercialization in the United States and Japan of several compou...
-
Biotech Boom in Medicon Valley
6 Sep 2007
The Medicon Valley biotech industry has matured to such an extent that an impressive 11 companies are considering an IPO within the coming three years. A big part of the companies will be Danish, but ...
-
Alligator Bioscience and SARomics Signs Collaboration Agreement
18 Sep 2007
Alligator Bioscience AB and SARomics AB have entered into a strategic collaboration agreement. Alligator Bioscience uses its proprietary FIND technology to develop new and optimize existing therapeuti...
-
NeuroSearch Announces Breakthrough Tesofensine Results
19 Sep 2007
NeuroSearch A/S has concluded a Phase IIb Proof-of-Concept and dose finding study, TIPO-1, with its drug candidate tesofensine for the treatment of obesity with very positive results. Data from the st...
-
Zealand Pharma’s IND for ZP1846 Approved by FDA
7 Sep 2007
FDA has approved Zealand Pharma A/S' Investigative New Drug application, IND, for ZP1846 to be administered in humans. ZP1846 is developed for the prevention and treatment of severe diarrhoea induced ...
{B7AA1864-79CF-4B1B-BC46-0F5121B9924A}.pdf
Medicon Valley Biomedical Newsletter is published by
Region Skåne and Copenhagen Capacity.
We assist foreign companies in finding locations and partnerships in Medicon Valley. We offer free assistance at each step of the business development phase. Visit www.mediconvalley.com or contact us to learn more about the opportunities that await your company in Medicon Valley.
|
Copenhagen Capacity |
Region Skåne |
If you have any comments on the Medicon Valley Biomedical Newsletter please contact the editor at info@mediconvalley.com.
Here you can subscribe to the Medicon Valley Academy Newsletter
The MVA newsletter is an e-mail news service for Medicon Valley Academy (MVA) members and other actors within life science. The newsletter brings you information on new MVA initiatives and activities, editorials on issues of topical interest, news from the region together with available jobs and relevant life science events.
Click here to subscribe or visit www.mva.org.